Clinical trials
Colic trials with no applicable phase
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
77 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2005 | 1 |
| 2006 | 1 |
| 2007 | 1 |
| 2008 | 2 |
| 2009 | 2 |
| 2011 | 3 |
| 2012 | 2 |
| 2013 | 1 |
| 2014 | 3 |
| 2015 | 4 |
| 2016 | 6 |
| 2017 | 5 |
| 2018 | 5 |
| 2019 | 2 |
| 2020 | 5 |
| 2021 | 5 |
| 2022 | 10 |
| 2023 | 2 |
| 2024 | 8 |
| 2025 | 7 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 40 |
| Unknown status | 13 |
| Terminated | 8 |
| Recruiting | 7 |
| Not yet recruiting | 4 |
| Active, not recruiting | 3 |
| Withdrawn | 2 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| BioGaia AB | 5 |
| Karamanoğlu Mehmetbey University | 3 |
| European School of Osteopathy | 2 |
| Federico II University | 2 |
| Nordic Institute of Chiropractic and Clinical Biomechanics | 2 |
| The University of Texas Health Science Center, Houston | 2 |
| University of Seville | 2 |
| AB Biotics, SA | 1 |
| Abant Izzet Baysal University | 1 |
| Akdeniz University | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Colic | 77 |
| Constipation | 6 |
| Gastroesophageal Reflux | 5 |
| Gastrointestinal Diseases | 5 |
| Depression, Postpartum | 4 |
| Gallstones | 3 |
| Abdominal Pain | 2 |
| Inflammation | 2 |
| Cholecystitis | 1 |
| Cholelithiasis | 1 |
Trials
Showing 51 to 75 of 77. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.